SCHEMBL19857547

SCHEMBL19857547

Cc1cc2cccc(C(N)=O)n2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK8 P49336 2/20 0.43
AURKA O14965 1/20 0.43
CSF1R P07333 1/20 0.43
RET P07949 1/20 0.43
LTK P29376 1/20 0.43
CSNK1A1 P48729 1/20 0.43
CLK2 P49760 1/20 0.43
CDK5 Q00535 1/20 0.43
ACVR1 Q04771 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
TGFBR1 P36897 2/20 0.39
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
PARP1 P09874 3/20 0.38
ENPP3 O14638 3/20 0.36
ALPL P05186 3/20 0.36
XIAP P98170 3/20 0.36
LMNA P02545 2/20 0.36
RIPK2 O43353 1/20 0.36
HTR4 Q13639 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30521624 0.84 GRN (0.41) ALDH1A1ENPP3ALPLXIAPLMNA
SCHEMBL22577772 0.82 HTR4 (0.52) CDK8AURKACSF1RRETLTK
SCHEMBL24371481 0.80 GAA (0.40) ALDH1A1HPGDLMNAHTR4KDM4E
SCHEMBL22577770 0.74 HTR4 (0.38) HTR4KDM4EGAA
SCHEMBL7947758 0.74 ENPP3 (0.39) ALDH1A1PARP1ENPP3ALPLXIAP
SCHEMBL22235731 0.71 IRAK4 (0.42) CDK8AURKARETLTKCSNK1A1
SCHEMBL22582783 0.71 TLR8 (0.40) CDK8AURKACSF1RRETLTK
SCHEMBL13908966 0.71 ENPP3 (0.33) ALDH1A1PARP1ENPP3ALPLXIAP
SCHEMBL4035386 0.71 AHR (0.35) ALDH1A1HPGDPARP1ENPP3ALPL
SCHEMBL5847269 0.71 ENPP3 (0.33) ALDH1A1PARP1ENPP3ALPLXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4188094-A1 A PESTICIDALLY ACTIVE MIXTURE COMPRISING PYRAZOLOPYRIDINE ANTHRANILAMIDE COMPOUND, OXIDES OR SALTS THEREOF PI Industries Ltd. (IN) 2023-06-07 EP claimed
WO-2022023931-A1 A PESTICIDALLY ACTIVE MIXTURE COMPRISING PYRAZOLOPYRIDINE ANTHRANILAMIDE COMPOUND, OXIDES OR SALTS THEREOF PI INDUSTRIES LTD (IN) 2022-02-03 WO claimed
EP-3728256-A1 PYRAZOLOPYRIDINE-DIAMIDES, THEIR USE AS INSECTICIDE AND PROCESSES FOR PREPARING THE SAME PI Industries Ltd. (IN) 2020-10-28 EP claimed
US-12024510-B2 Pyrazolopyridine-diamides, their use as insecticide and processes for preparing the same PI INDUSTRIES LTD. (IN) 2024-07-02 US disclosed
US-20200339578-A1 PYRAZOLOPYRIDINE-DIAMIDES, THEIR USE AS INSECTICIDE AND PROCESSES FOR PREPARING THE SAME PI INDUSTRIES LTD. (IN) 2020-10-29 US disclosed
EP-3728256-A1 PYRAZOLOPYRIDINE-DIAMIDES, THEIR USE AS INSECTICIDE AND PROCESSES FOR PREPARING THE SAME PI Industries Ltd. (IN) 2020-10-28 EP disclosed
US-10174005-B2 Fused pyrimidines as inhibitors of p97 complex CLEAVE BIOSCIENCES, INC. (US) 2019-01-08 US disclosed
US-20180044325-A1 FUSED PYRIMIDINES AS INHIBITORS OF P97 COMPLEX CLEAVE BIOSCIENCES, INC. 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10174005-B2 Fused pyrimidines as inhibitors of p97 complex WDR77, POP1, PSMG3 CDK8 1805/4885AURKA 935/4885CSF1R 4058/4885
US-12024510-B2 Pyrazolopyridine-diamides, their use as insecticide and processes for preparing the same DDT, QDPR, CYP1A1 CDK8 3528/4885AURKA 1860/4885CSF1R 3636/4885
US-20180044325-A1 FUSED PYRIMIDINES AS INHIBITORS OF P97 COMPLEX WDR77, POP1, PSMG3 CDK8 1789/4885AURKA 892/4885CSF1R 4058/4885
US-20200339578-A1 PYRAZOLOPYRIDINE-DIAMIDES, THEIR USE AS INSECTICIDE AND PROCESSES FOR PREPARING THE SAME DDT, QDPR, CYP1A1 CDK8 3528/4885AURKA 1860/4885CSF1R 3636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.